Cawthorn and coworkers found that high decorin expression was associated with lymph node metastasis and poor clinical outcome in breast cancer; thus, decorin was proposed as an adverse prognostic and predictive biomarker [45]. Here, DCN is linked to metastatic malignant neoplasm in the lymph nodes.